O	0	3	The
O	4	10	Effect
O	11	13	of
B-intervention	14	24	Counseling
I-intervention	25	27	on
I-intervention	28	34	Breast
I-intervention	35	41	Cancer
I-intervention	42	51	Awareness
O	52	54	in
O	55	60	Rural
B-ethinicity	61	68	Iranian
O	69	74	Women
O	74	75	:
O	76	77	a
O	78	88	Randomized
O	89	99	Controlled
O	100	108	Clinical
O	109	114	Trial
O	114	115	.

O	116	118	In
O	119	120	a
O	121	130	community
O	131	135	such
O	136	138	as
O	139	143	Iran
O	144	149	where
O	150	154	late
O	155	167	presentation
O	168	170	is
O	171	182	predominant
O	183	186	and
O	187	190	the
O	191	199	majority
O	200	202	of
O	203	209	breast
O	210	216	cancer
O	217	225	patients
O	226	229	are
O	230	239	diagnosed
O	240	242	at
O	243	251	advanced
O	252	258	stages
O	259	261	of
O	262	265	the
O	266	273	disease
O	273	274	,
O	275	280	there
O	281	283	is
O	284	286	an
O	287	293	urgent
O	294	298	need
O	299	302	for
O	303	312	improving
O	313	316	the
O	317	322	level
O	323	325	of
O	326	335	awareness
O	336	341	about
O	342	348	breast
O	349	355	cancer
O	356	359	and
O	360	365	early
O	366	375	detection
O	376	384	measures
O	384	385	.

O	386	391	Given
O	392	396	that
O	397	402	rural
O	403	412	residents
O	413	416	are
O	417	419	at
O	420	426	higher
O	427	431	risk
O	432	435	for
O	436	440	late
O	441	450	diagnosis
O	451	453	of
O	454	460	breast
O	461	467	cancer
O	468	475	because
O	476	480	they
O	481	485	have
O	486	490	less
O	491	500	education
O	500	501	,
O	502	508	income
O	508	509	,
O	510	513	and
O	514	520	access
O	521	523	to
O	524	532	advanced
O	533	542	screening
O	543	555	technologies
O	555	556	,
O	557	561	this
O	562	567	study
O	568	571	was
O	572	581	conducted
O	582	584	to
O	585	594	determine
O	595	598	the
O	599	605	effect
O	606	608	of
O	609	619	counseling
O	620	622	on
O	623	629	breast
O	630	636	cancer
O	637	646	awareness
O	647	649	of
O	650	655	rural
O	656	663	Iranian
O	664	669	women
O	669	670	.

O	671	675	This
O	676	686	randomized
O	687	695	clinical
O	696	701	trial
O	702	705	was
O	706	715	conducted
O	716	718	on
B-total-participants	719	721	60
B-eligibility	722	727	rural
I-eligibility	728	733	women
O	734	738	from
O	739	742	the
B-location	743	748	Abish
I-location	749	754	Ahmad
O	755	759	area
O	760	762	in
B-location	763	775	northwestern
I-location	776	780	Iran
O	781	783	in
O	784	788	2017
O	788	789	.

O	790	793	The
O	794	804	randomized
O	805	812	cluster
O	813	819	method
O	820	823	was
O	824	828	used
O	829	832	for
O	833	841	sampling
O	841	842	.

O	843	847	From
O	848	850	20
O	851	856	rural
O	857	863	health
O	864	870	houses
O	871	874	and
O	875	882	centers
O	882	883	,
O	884	889	about
O	890	893	one
O	894	899	third
O	900	904	were
O	905	913	selected
O	914	922	randomly
O	922	923	.

O	924	928	From
O	929	932	the
O	933	936	six
O	937	945	selected
O	946	954	clusters
O	954	955	,
O	956	961	three
O	962	966	were
O	967	975	randomly
O	976	985	allocated
O	986	988	as
O	989	992	the
O	993	1000	control
O	1001	1006	group
O	1007	1010	and
O	1011	1016	three
O	1017	1019	as
O	1020	1023	the
O	1024	1036	intervention
O	1037	1042	group
O	1042	1043	.

O	1044	1049	Using
O	1050	1061	convenience
O	1062	1070	sampling
O	1070	1071	,
B-control-participants	1072	1074	30
O	1075	1080	women
O	1081	1088	between
O	1089	1092	the
O	1093	1097	ages
O	1098	1100	of
O	1101	1103	40
O	1104	1107	and
O	1108	1110	69
O	1111	1115	were
O	1116	1124	selected
O	1125	1129	from
O	1130	1133	the
B-control	1134	1141	control
I-control	1142	1147	group
O	1148	1151	and
B-intervention-participants	1152	1154	30
O	1155	1159	from
O	1160	1163	the
O	1164	1176	intervention
O	1177	1182	group
O	1182	1183	.

O	1184	1187	The
O	1188	1200	intervention
O	1201	1206	group
O	1207	1215	attended
O	1216	1219	six
O	1220	1225	group
O	1226	1236	counseling
O	1237	1245	sessions
O	1245	1246	.

O	1247	1251	Data
O	1252	1255	was
O	1256	1264	gathered
O	1265	1270	using
O	1271	1272	a
O	1273	1284	demographic
O	1285	1288	and
O	1289	1300	obstetrical
O	1301	1312	information
O	1313	1326	questionnaire
O	1327	1330	and
O	1331	1337	breast
O	1338	1344	cancer
O	1345	1354	awareness
O	1355	1363	measures
O	1363	1364	.

O	1365	1368	The
O	1369	1372	chi
O	1372	1373	-
O	1373	1379	square
O	1379	1380	,
O	1381	1392	independent
O	1393	1394	t
O	1395	1399	test
O	1400	1403	and
O	1404	1410	ANCOVA
O	1411	1413	by
O	1414	1425	controlling
O	1426	1429	for
O	1430	1433	the
O	1434	1442	baseline
O	1443	1449	scores
O	1450	1454	were
O	1455	1459	used
O	1460	1462	to
O	1463	1470	analyze
O	1471	1474	the
O	1475	1479	data
O	1479	1480	.

O	1481	1486	After
O	1487	1497	counseling
O	1497	1498	,
O	1499	1502	the
B-outcome	1503	1507	mean
I-outcome	1508	1517	knowledge
I-outcome	1518	1523	about
I-outcome	1524	1530	breast
I-outcome	1531	1537	cancer
I-outcome	1538	1543	score
O	1544	1547	was
O	1548	1561	significantly
O	1562	1568	higher
O	1569	1571	in
O	1572	1575	the
O	1576	1588	intervention
O	1589	1594	group
O	1595	1599	than
O	1600	1602	in
O	1603	1606	the
O	1607	1614	control
O	1615	1620	group
O	1621	1622	(
O	1622	1630	adjusted
O	1631	1635	mean
O	1636	1646	difference
O	1646	1647	,
O	1648	1650	17
O	1650	1651	.
O	1651	1653	02
O	1653	1654	;
O	1655	1665	confidence
O	1666	1674	interval
O	1675	1676	(
O	1676	1678	CI
O	1678	1679	)
O	1680	1682	95
O	1682	1683	%
O	1683	1684	,
O	1685	1687	15
O	1687	1688	.
O	1688	1690	44
O	1691	1693	to
O	1694	1696	18
O	1696	1697	.
O	1697	1699	59
O	1699	1700	;
O	1701	1702	p
O	1703	1704	<
O	1705	1706	0
O	1706	1707	.
O	1707	1710	001
O	1710	1711	)
O	1711	1712	.

O	1713	1716	The
O	1717	1721	mean
B-outcome	1722	1730	barriers
I-outcome	1731	1733	to
I-outcome	1734	1740	breast
I-outcome	1741	1747	cancer
I-outcome	1748	1757	screening
I-outcome	1758	1763	score
O	1764	1770	showed
O	1771	1772	a
O	1773	1784	significant
O	1785	1793	decrease
O	1794	1796	in
O	1797	1800	the
O	1801	1813	intervention
O	1814	1819	group
O	1820	1828	compared
O	1829	1831	to
O	1832	1835	the
O	1836	1843	control
O	1844	1849	group
O	1850	1851	(
O	1851	1854	AMD
O	1854	1855	,
O	1856	1857	-
O	1858	1859	1
O	1859	1860	.
O	1860	1862	74
O	1862	1863	;
O	1864	1866	95
O	1866	1867	%
O	1868	1870	CI
O	1871	1872	-
O	1873	1874	3
O	1874	1875	.
O	1875	1877	12
O	1878	1880	to
O	1881	1882	-
O	1883	1884	0
O	1884	1885	.
O	1885	1887	36
O	1887	1888	,
O	1889	1890	p
O	1891	1892	<
O	1893	1894	0
O	1894	1895	.
O	1895	1898	001
O	1898	1899	)
O	1899	1900	.

O	1901	1906	After
O	1907	1919	intervention
O	1919	1920	,
O	1921	1924	the
B-outcome	1925	1934	frequency
I-outcome	1935	1937	of
I-outcome	1938	1944	breast
I-outcome	1945	1949	self
I-outcome	1949	1950	-
I-outcome	1950	1954	exam
O	1955	1961	showed
O	1962	1963	a
O	1964	1975	significant
O	1976	1986	difference
O	1987	1994	between
O	1995	2001	groups
O	2002	2003	(
O	2003	2004	p
O	2005	2006	<
O	2007	2008	0
O	2008	2009	.
O	2009	2012	001
O	2012	2013	)
O	2013	2014	;
O	2015	2018	but
O	2019	2022	for
O	2023	2033	confidence
O	2034	2039	about
O	2040	2048	noticing
O	2049	2055	breast
O	2056	2063	changes
O	2063	2064	,
O	2065	2067	no
O	2068	2079	significant
O	2080	2090	difference
O	2091	2094	was
O	2095	2103	observed
O	2104	2111	between
O	2112	2118	groups
O	2119	2120	(
O	2120	2121	p
O	2122	2123	=
O	2124	2125	0
O	2125	2126	.
O	2126	2128	08
O	2128	2129	)
O	2129	2130	.

O	2131	2136	Group
O	2137	2147	counseling
O	2148	2151	had
O	2152	2153	a
O	2154	2165	significant
O	2166	2172	effect
O	2173	2175	on
O	2176	2185	enhancing
O	2186	2192	breast
O	2193	2199	cancer
O	2200	2209	awareness
O	2210	2212	of
O	2213	2218	rural
O	2219	2226	Iranian
O	2227	2232	women
O	2232	2233	,
O	2234	2240	except
O	2241	2244	for
O	2245	2255	confidence
O	2256	2261	about
O	2262	2270	noticing
O	2271	2277	breast
O	2278	2285	changes
O	2285	2286	.
